Robin Roberts, COO and co-founder of the Novartis Biome, was on site at JP Morgan last month in San Francisco, but we weren’t able to pin him down for an interview.
Endeavor BioMedicines has completed a third-round financing, raising an impressive $132.5 million to fund trials of its two clinical-stage drug candidates for pulmonary fi
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.